双锁SARS-CoV-2尖端剪切器:一个两性分子"螺栓"稳定了用于冠状病毒抑制的保存药物接口
Shiliang Li1,2,3, Fang Ye4, Yucheng Zheng5
1Innovation Center for AI and Drug Discovery, School of Pharmacy, East China Normal University, Shanghai, 200062, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|April 26, 2025
概括
一个新型分子,S416,作为一个分子螺栓来稳定SARS-CoV-2尖端蛋白. 这种双锁机制有效地抑制病毒的进入,为冠状病毒提供广泛的抗病毒策略.
科学领域:
- 病毒学 病毒学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- SARS-CoV-2 尖端蛋白对于宿主细胞进入至关重要.
- 稳定尖端蛋白的闭合构造是关键的抗病毒策略.
- 现有的尖端蛋白稳定方法具有挑战性.
研究的目的:
- 引入S416,一种用于稳定SARS-CoV-2尖端蛋白的新型分子螺栓.
- 阐明S416.6的结合机制和结构效应.
- 探索S416作为广泛的抗病毒药物的潜力.
主要方法:
- 电子显微镜 (Cryo-EM) 用于确定与S416结合的尖端蛋白的结构.
- 生物物理分析以评估S416.的稳定作用.
- 与阿波尖端蛋白质结构进行比较分析.
主要成果:
- 在RBD-RBD和NTD-RBD接口中,S416结合到6个位点,作为一个分子螺栓.
- 双锁机制可在封闭的形状下强大稳定尖端剪切器.
- S416显著降低了尖端蛋白的结构灵活性和原子波动.
- 在感染人类的冠状病毒中确定了保守的接口.
结论:
- 在封闭状态下,S416有效地稳定了SARS-CoV-2尖端剪切器.
- 已识别的结合接口在人类冠状病毒中保留着,这表明具有广泛的潜力.
- 向单体间和单体内接口的两性分子提供了一个有前途的抗病毒策略.
相关概念视频
Protein-protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Protein-Protein Interfaces
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


